Deregulations in the Cyclin-Dependent Kinase-9-Related Pathway in Cancer: Implications for Drug Discovery and Development
Figure 1
This figure displays the binding partners for Cdk9: cyclin K, cyclin T1, and cyclin T2a. Cyclin T2b is very similar to cyclin T2a and is not shown. Abbreviation: PHE: phenylalanine.